Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Incyte Corporation
University Hospital, Essen
Ohio State University Comprehensive Cancer Center
Fate Therapeutics
Incyte Corporation